Data Snapshot: Sep 06, 2026
$100K+

Aug-2026

Sales

Neutral

Trend

6-Month

105

Product Count

SKUs

$19.67

Avg Price

-18.7%

YoY Sales Change

0.1%

YoY Price Change

With a unique combination of ancient herbology and modern technology, Fairwinds Manufacturing is a distinguished pesticide-free cannabis manufacturer operating in Washington State since 2014. The company, known for its customer-praised CBD-enhanced wellness products, capitalizes on the nationwide legalization trend to redefine societal approaches to health. Fairwinds' notable efficiency and consistency result from using an automated cultivation facility specifically designed for replicable results.
Fairwinds

Where to Buy

Fairwinds is stocked at 209 licensed dispensaries across Washington, with the deepest coverage in Seattle, Spokane, Tacoma, Vancouver, and Everett. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.

https://headsetstorage.blob.core.windows.net/brand-stores/102.json?v=20260905
Fairwinds Sales

Market Insights Snapshot

Fairwinds Historical Sales by Category

Fairwinds’ August 2026 mix tilted further toward Tincture & Sublingual at 49.75% share, yet that anchor category declined 18.19% year over year and 27.55% month over month, pulling total brand sales down 18.68% YoY even as average price edged up 0.12%. Offsetting that drag, Vapor Pens expanded to 23.97% share with 19.57% YoY growth and 10.02% MoM growth, while Capsules at 12.80% share fell 40.10% YoY and 4.68% MoM, and Topical at 11.87% share slid 26.66% YoY and 2.33% MoM; the long tail eroded as Concentrates dropped 48.83% YoY and 5.21% MoM and Pre-Roll plunged 91.03% YoY and 32.07% MoM. The pattern implies the brand is increasingly dependent on a shrinking core while momentum concentrates in Vapor Pens, creating a mix that amplifies volatility when the largest category retrenches.

Holding rank 2 in Tincture & Sublingual in Washington while that category is down 27.55% MoM and 18.19% YoY suggests Fairwinds retains placement but with a weakening demand base, and the 0.12% YoY price increase alongside a 34.63% 24‑month sales contraction points to a volume-led slide rather than pricing pressure. With Vapor Pens posting 19.57% YoY and 10.02% MoM gains against double‑digit YoY declines in Capsules (40.10%) and Topical (26.66%), the near-term positioning opportunity is to accelerate SKU and distribution shifts toward higher-velocity pens while ring‑fencing the Tincture & Sublingual leadership to avoid further mix exposure that compounds downturns.

Aug-2026 Rank
Capsules
Tincture & Sublingual
Topical
Vapor Pens
2
2
4
82
Category
Share of Sales
Avg Item Price
YoY %
MoM %
Tincture & Sublingual
49.8%
$20.08
-18.2%
-27.5%
Vapor Pens
24.0%
$20.44
+19.6%
+10.0%
Capsules
12.8%
$16.71
-40.1%
-4.7%
Topical
11.9%
$20.09
-26.7%
-2.3%
Concentrates
1.2%
$25.30
-48.8%
-5.2%
Flower
0.4%
$15.38
-80.1%
+0.3%
Pre-Roll
0.0%
$6.76
-91.0%
-32.1%
Fairwinds

Competitive Landscape

Fairwinds sits at rank #2 in Washington Tincture & Sublingual for August 2026, unchanged from #2 year over year, with a three-month hold at #2 and a brief peak at #1 in July 2026; meanwhile, Green Revolution remains #1 but with a -13.6% year-over-year sales change, and HiKu climbed from #4 to #3 alongside a 44.8% year-over-year sales increase, indicating Fairwinds is defending share against a softening leader while pressure intensifies from a faster-rising challenger; this trajectory implies a stable second-place position that risks erosion if Fairwinds does not convert July 2026’s #1 peak into sustained gains.

Fairwinds market ranking for WA Tincture & Sublingual

Fairwinds

Notable Products

CBD/THC 5:1 Companion Savory Bacon 32x Tincture (100mg CBD, 20mg THC, 0.27 fl oz, 8ml) posted the steepest decline at -55.77% and slid to rank 3, while the larger CBD/THC 5:1 Companion Savory Bacon 64x Tincture (200mg CBD, 40mg THC, 8ml, 0.54 fl oz) fell -45.21% yet still held rank 1; together with CBD/CBN/THC 5:5:1 Deep Sleep Tincture (250mg CBD, 250mg CBN, 50mg THC, 0.45 fl oz) at rank 2 and -9.00%, this places four of the top ten in Tincture & Sublingual with mixed momentum across positions 1, 2, 3, and 9. CBD/CBN/THC 5:5:1 Deep Sleep Tincture at rank 2 narrowed the gap but did not overtake rank 1, while the CBD/THC 1:1 Ratio Tincture (100mg CBD, 100mg THC, 0.26oz) dropped -17.34% at rank 9, contrasting with the CBD/THC 20:1 Ratio Co2 Cartridge (1g) up +11.74% at rank 7; this divergence implies Fairwinds is overexposed to bacon-flavored and ratio-based tinctures as consumer pull migrates toward balanced cannabinoids in non-tincture forms.

Product
Category
Apr-2026
May-2026
Jun-2026
Jul-2026
Aug-2026
MoM %
CBD/THC 5:1 Companion Savory Bacon 64x Tincture (200mg CBD, 40mg THC, 8ml, 0.54 fl oz)
Tincture & Sublingual
1
1
1
1
1
-45.2%
CBD/CBN/THC 5:5:1 Deep Sleep Tincture (250mg CBD, 250mg CBN, 50mg THC, 0.45 fl oz)
Tincture & Sublingual
2
2
3
3
2
-9.0%
CBD/THC 5:1 Companion Savory Bacon 32x Tincture (100mg CBD, 20mg THC, 0.27 fl oz, 8ml)
Tincture & Sublingual
3
3
2
2
3
-55.8%
CBD/CBG/THC FECO High Potency 20-Pack (1000mg CBD, 1000mg CBG, 40mg THC)
Capsules
6
5
4
7
4
+10.9%
Indica Lifestyle Tincture (100mg)
Tincture & Sublingual
5
4
7
6
5
+0.9%
CBD/THC/CBG 1:1:1 Flow Cream Deep Tissue Relief (175mg CBD, 175mg THC, 175mg CBG, 1.1oz, 30g)
Topical
9
7
>10
8
6
+6.4%
CBD/THC 20:1 Ratio Co2 Cartridge (1g)
Vapor Pens
7
8
>10
10
7
+11.7%
CBD/THC/CBG 1:1:1 CO2 Cartridge (1g)
Vapor Pens
>10
>10
>10
>10
8
—
CBD/THC 1:1 Ratio Tincture (100mg CBD, 100mg THC, 0.26oz)
Tincture & Sublingual
4
6
5
5
9
-17.3%
CBD Sativa Lifestyle Tincture (100mg, 2oz)
Tincture & Sublingual
8
9
8
>10
10
—
View product & sales data

Top Selling Cannabis Brands

Simple, transparent pricing that grows with you.
Research the top cannabis brands across markets in the US and Canada.

Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.

Header image
User rating
start Today
Stay ahead of the competition with real-time market data insights.

Discover How Your Brand Stacks Up in the Market